CAR T-cell therapy is highly effective in stopping even advanced cancers, and uses the patient's own T-cells to attack and kill cancer cells.
The FDA has approved CAR T-cell therapy to treat several types of non-Hodgkin's lymphoma, multiple myeloma, and acute lymphoblastic leukemia. Research trials are underway exploring treating cancers of the breast, colon, brain, and lungs.
Currently, however, the closest treatment centers are in Salt Lake City and Seattle.